(Heat Biologics, Inc.)

	HTBX latest price $179.9000 (13.72%) ($140.0000 - $185.5000) on Fri. Jan. 22, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	17.05% (three month average)
RSI	58
Latest Price	$179.9000(13.72%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	HTBX advances 0.9% a day on average for past five trading days.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support HTBX advance at 0% a week (0% probability)   SKYY(9%)    ARKK(8%)    FXI(8%)    MCHI(8%)    QQQ(8%)
Factors Impacting HTBX price	HTBX will decline at least -8.525% in a week (0% probabilities).   VIXM(-7%)    VCSH(-6%)    GDXJ(-4%)    UUP(-3%)    SHY(-2%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-8.525% (StdDev 17.05%)
Hourly BBV	0 ()
Intraday Trend	17.9%

5 Day Moving Average	$163.8(9.83%)
10 Day Moving Average	$169.71(6%)
20 Day Moving Average	$0(INF%)
To recent high	-40.5%
To recent low	20.1%
Market Cap	$19.793b

Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.

getNextHourMoveProbability failed